CClinicalTrials.gg
CompletedNCT04792242Updated Mar 23, 2021

Effect of PCO2 Gap Algorithm Application on Outcome of High Risk Surgical Patients Undergoing Major Abdominal Surgeries

An interventional study of cv line insertion and Urinary catheter insertion in Major Abdominal Surgeries, sponsored by South Valley University. Completed at 1 site in Egypt. Per ClinicalTrials.gov, last updated 2021-03-23.

Sponsored by South Valley University · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Registered 1 year 3 months after the study started (first participant enrolled Nov 2019, registered Mar 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Sex
All
01

Study summary

  1. Primary (main):

    Comparison between goal directed therapy and PCO2 gap algorithm (carbon dioxide partial pressure venous arterial gap algorithm) application on 30 days mortality and organ dysfunction post operative

  2. Secondary (subsidiary):

Comparison between goal directed therapy and PCO2 gap algorithm application on number of ventilator dependant days, number of days on vasopressors or inotropes length of ICU stay, length of hospital stay,

Read the detailed description

High risk surgical participants in South valley university hospitals (teaching hospitals) who will undergo major abdominal surgeries will be included in research after giving written informed consent from the participants or from the patient's legal representative. The use of obtained data will be approved by local ethics committee.

All participants will be evaluated pre operatively and pre medicated according to protocols in our hospital, base line sequential organ failure (SOFA) score will be taken. General anesthesia for all patients will be carried on according to our local standards. As part of our routine hemodynamic monitoring during major surgery, all patients will be monitored with central venous (standard three-lumen catheter) and arterial catheters placed before the beginning of surgery. The central venous line will be positioned with the tip within the superior vena cava, and correct positioning will be verified by chest radiograph.

the participants will be divided randomly onto to groups using numerical system group A PCO2 gap algorithm(carbon dioxide partial pressure venous arterial gap) will be applied intraoperative and 12 h postoperative end point PCO2 gap 2-6mm Hg(appendix 1).

Group B goal directed therapy protocol which will include targets mean arterial blood pressure ( MAP) > 65 mmHg, central venous pressure(CVP) between 8-12 cmH2O , Haematocrite value more than 30, mixed venous oxygen saturation (Svo2) >75% and urine output more than >0.5 ml/kg/hr and will be applied intraoperative and 12 postoperative end point base deficit +/- 2(appendix 2 ).

All participants will be admitted to the ICU (intensive care unit) immediately after surgery .Standard postoperative monitoring will include: electrocardiograph (heart rate), invasive mean arterial pressure, pulse oxygen saturation and urine output then will be all managed according to their allocated group for 12 hours.

Outcomes in both groups will be recorded which will be number of ventilator dependant days, number of days on vasopressors or inotropes length of ICU stay, length of hospital stay, 30 days organ dysfunction, assessed by using the Sequential Organ Failure Assessment (SOFA) and 30 days mortality .

02

Conditions studied

  • Major Abdominal Surgeries
03

In context

Lead sponsor

South Valley University is the lead sponsor of 147 studies on the registry; 46 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Clinical criteria for high-risk surgical patients used by Shoemaker and colleagues and adapted by Boyd and colleagues

Exclusion criteria

Exclusion Criteria:

  • patients who will refuse to continue on research patients who will not be admitted post operative in the ICU
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
40 participants (actual)

Study arms

  • Active comparator
    goal directed therapy

    svo2,haematocrite value,urine output,mean arterial pressure and central venous pressure

    Device: cv line insertion · Device: Urinary catheter insertion

  • Active comparator
    PCO2 gap algorithm

    PCO2 gap,haematocrite value,Spo2,cardiac index

    Device: cv line insertion · Device: Urinary catheter insertion · Device: Arterial line

Interventions

  • Devicecv line insertion

    Svo2 and central venous pressure measurements

  • DeviceUrinary catheter insertion

    urine output measurement

  • DeviceArterial line

    Arterial blood gases measurment

06

What researchers measure

Primary outcomes

  1. Post operative mortality

    early post operative mortality

    Time frame: 30 days

Secondary outcomes

  1. post operative organ failure

    cardiac,renal,respiratory,renal central nervous system(CNS) failure by sequential organ failure(SOFA) score

    Time frame: 30 days

07

Study locations

1 site
  • South Valley University
    Luxor, Qena 83523, Egypt
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 23, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04792242
Lead sponsor
South Valley University
Responsible party
Hassan Abdelsapour Abdelrazek (PhD Candidat, South Valley University) — Principal investigator
First posted
Mar 10, 2021
Start date
Nov 10, 2019
Primary completion
Dec 21, 2020
Completion
Mar 7, 2021
Last update
Mar 23, 2021

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion